Highly homogeneous antibody modification through optimisation of the synthesis and conjugation of functionalised dibromopyridazinediones
出版年份 2018 全文链接
标题
Highly homogeneous antibody modification through optimisation of the synthesis and conjugation of functionalised dibromopyridazinediones
作者
关键词
-
出版物
ORGANIC & BIOMOLECULAR CHEMISTRY
Volume 16, Issue 8, Pages 1359-1366
出版商
Royal Society of Chemistry (RSC)
发表日期
2018-01-30
DOI
10.1039/c7ob03138f
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Forming next-generation antibody–nanoparticle conjugates through the oriented installation of non-engineered antibody fragments
- (2018) Michelle K. Greene et al. Chemical Science
- Enabling the controlled assembly of antibody conjugates with a loading of two modules without antibody engineering
- (2017) Maximillian T. W. Lee et al. Chemical Science
- Pyridazinediones deliver potent, stable, targeted and efficacious antibody–drug conjugates (ADCs) with a controlled loading of 4 drugs per antibody
- (2017) Eifion Robinson et al. RSC Advances
- Recent advances in the construction of antibody–drug conjugates
- (2016) Vijay Chudasama et al. Nature Chemistry
- Dual modification of biomolecules
- (2016) Antoine Maruani et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Next-generation disulfide stapling: reduction and functional re-bridging all in one
- (2016) Maximillian T. W. Lee et al. Chemical Science
- The use of 3,6-pyridazinediones in organic synthesis and chemical biology
- (2016) Maximillian T. W. Lee et al. JOURNAL OF CHEMICAL RESEARCH
- Site-selective multi-porphyrin attachment enables the formation of a next-generation antibody-based photodynamic therapeutic
- (2015) Antoine Maruani et al. CHEMICAL COMMUNICATIONS
- Functional native disulfide bridging enables delivery of a potent, stable and targeted antibody–drug conjugate (ADC)
- (2015) João P. M. Nunes et al. CHEMICAL COMMUNICATIONS
- Advances in Chemical Protein Modification
- (2015) Omar Boutureira et al. CHEMICAL REVIEWS
- In Vitro and In Vivo Evaluation of Cysteine Rebridged Trastuzumab–MMAE Antibody Drug Conjugates with Defined Drug-to-Antibody Ratios
- (2015) Penny Bryant et al. MOLECULAR PHARMACEUTICS
- Site-selective protein-modification chemistry for basic biology and drug development
- (2015) Nikolaus Krall et al. Nature Chemistry
- A dual optical and nuclear imaging reagent for peptide labelling via disulfide bridging
- (2015) Sally A. Fletcher et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- A novel synthetic chemistry approach to linkage-specific ubiquitin conjugation
- (2015) Rachel E. Morgan et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy
- (2015) Antoine Maruani et al. Nature Communications
- Bridging Disulfides for Stable and Defined Antibody Drug Conjugates
- (2014) George Badescu et al. BIOCONJUGATE CHEMISTRY
- Homogeneous Bispecifics by Disulfide Bridging
- (2014) Elizabeth A. Hull et al. BIOCONJUGATE CHEMISTRY
- Aryloxymaleimides for cysteine modification, disulfide bridging and the dual functionalization of disulfide bonds
- (2014) Cristina Marculescu et al. CHEMICAL COMMUNICATIONS
- Site-Specific Trastuzumab Maytansinoid Antibody–Drug Conjugates with Improved Therapeutic Activity through Linker and Antibody Engineering
- (2014) Thomas H. Pillow et al. JOURNAL OF MEDICINAL CHEMISTRY
- Next generation maleimides enable the controlled assembly of antibody–drug conjugates via native disulfide bond bridging
- (2014) Felix F. Schumacher et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Selective chemical protein modification
- (2014) Christopher D. Spicer et al. Nature Communications
- A mild synthesis of N-functionalised bromomaleimides, thiomaleimides and bromopyridazinediones
- (2013) Lourdes Castañeda et al. TETRAHEDRON LETTERS
- Homogeneous antibody fragment conjugation by disulfide bridging introduces ‘spinostics’
- (2013) Felix F. Schumacher et al. Scientific Reports
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bromopyridazinedione-mediated protein and peptide bioconjugation
- (2011) Vijay Chudasama et al. CHEMICAL COMMUNICATIONS
- Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
- (2010) J. R. Junutula et al. CLINICAL CANCER RESEARCH
- Trastuzumab
- (2010) Karly P. Garnock-Jones et al. DRUGS
- Protein Modification, Bioconjugation, and Disulfide Bridging Using Bromomaleimides
- (2010) Mark E. B. Smith et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now